1
Clinical Trials associated with Proteosome-adjuvanted trivalent inactivated influenza vaccine(GlaxoSmithKline)Study to Determine if Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine is Safe, Immunogenic and Efficacious in the Influenza Human Viral Challenge Model
A study to compare multiple dosage regimes of a protesomal intranasal vaccine.
100 Clinical Results associated with Proteosome-adjuvanted trivalent inactivated influenza vaccine(GlaxoSmithKline)
100 Translational Medicine associated with Proteosome-adjuvanted trivalent inactivated influenza vaccine(GlaxoSmithKline)
100 Patents (Medical) associated with Proteosome-adjuvanted trivalent inactivated influenza vaccine(GlaxoSmithKline)
100 Deals associated with Proteosome-adjuvanted trivalent inactivated influenza vaccine(GlaxoSmithKline)